BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10982006)

  • 1. Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization.
    Maruno M; Ninomiya H; Ghulam Muhammad AK; Hirata M; Kato A; Yoshimine T
    Brain Tumor Pathol; 2000; 17(1):21-7. PubMed ID: 10982006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Kato A; Hayakawa T
    Cancer Lett; 1999 Jan; 135(1):61-6. PubMed ID: 10077222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evidence of distinct subgroups of astrocytic tumors defined by comparative genomic hybridization.
    Nishizaki T; Kubota H; Harada K; Harada K; Ito H; Suzuki M; Sasaki K
    Hum Pathol; 2000 May; 31(5):608-14. PubMed ID: 10836301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.
    Arslantas A; Artan S; Oner U; Müslümanoglu MH; Ozdemir M; Durmaz R; Arslantas D; Vural M; Cosan E; Atasoy MA
    Pathol Oncol Res; 2007; 13(1):39-46. PubMed ID: 17387387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome DNA imbalances in human astrocytic tumors: a comparative genomic hybridization study of 63 Chinese patients.
    Jin S; Sun C; Yu S; Wang Q; Wu W; Sun Y; Zhao W; An T
    Pathol Res Pract; 2010 Oct; 206(10):674-81. PubMed ID: 20591577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization.
    Nishizaki T; Ozaki S; Harada K; Ito H; Arai H; Beppu T; Sasaki K
    Genes Chromosomes Cancer; 1998 Apr; 21(4):340-6. PubMed ID: 9559346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
    Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.
    Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E
    Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic alterations in glioblastomas with oligodendroglial component.
    Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
    Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
    Ramkissoon SH; Bi WL; Schumacher SE; Ramkissoon LA; Haidar S; Knoff D; Dubuc A; Brown L; Burns M; Cryan JB; Abedalthagafi M; Kang YJ; Schultz N; Reardon DA; Lee EQ; Rinne ML; Norden AD; Nayak L; Ruland S; Doherty LM; LaFrankie DC; Horvath M; Aizer AA; Russo A; Arvold ND; Claus EB; Al-Mefty O; Johnson MD; Golby AJ; Dunn IF; Chiocca EA; Trippa L; Santagata S; Folkerth RD; Kantoff P; Rollins BJ; Lindeman NI; Wen PY; Ligon AH; Beroukhim R; Alexander BM; Ligon KL
    Neuro Oncol; 2015 Oct; 17(10):1344-55. PubMed ID: 25754088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
    Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
    J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.